JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Home・Elenco Azioni・CEL-SCI Corp

CEL-SCI Corp

Chiusa

SettoreSettore sanitario

7.01

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.91

Massimo

7.3

Metriche Chiave
By Trading Economics
Entrata	908K -5.7M
EPS	-1.36
Margine di Profitto	-118.811
EBITDA	890K -4.5M

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	25M 73M
Apertura precedente	7.01
Chiusura precedente	7.01

Notizie sul Sentiment di mercato

By Acuity

25%

75%

43 / 373 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

N/A / 0.2494 Supporto e resistenza

CEL-SCI Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

3 nov 2025, 21:44 UTC

Utili

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 nov 2025, 23:44 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 nov 2025, 23:34 UTC

Discorsi di Mercato

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 nov 2025, 23:28 UTC

Utili

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 nov 2025, 23:24 UTC

Utili

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov 2025, 23:14 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Global Equities Roundup: Market Talk

3 nov 2025, 23:14 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 nov 2025, 23:12 UTC

Utili

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov 2025, 23:09 UTC

Utili

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 nov 2025, 23:09 UTC

Utili

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 nov 2025, 23:09 UTC

Utili

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 nov 2025, 23:06 UTC

Discorsi di Mercato

Utili

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 nov 2025, 22:36 UTC

Discorsi di Mercato

Utili

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 nov 2025, 22:31 UTC

Utili

Franco-Nevada 3Q EPS $1.49 >FNV

3 nov 2025, 22:31 UTC

Utili

Franco-Nevada 3Q Rev $487.7M >FNV

3 nov 2025, 22:24 UTC

Discorsi di Mercato

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 nov 2025, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 nov 2025, 21:59 UTC

Discorsi di Mercato

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 nov 2025, 21:54 UTC

Discorsi di Mercato

Utili

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 nov 2025, 21:54 UTC

Discorsi di Mercato

Utili

Global Equities Roundup: Market Talk

3 nov 2025, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

3 nov 2025, 21:49 UTC

Utili

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 nov 2025, 21:40 UTC

Utili

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 nov 2025, 21:31 UTC

Discorsi di Mercato

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 nov 2025, 21:19 UTC

Utili

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 nov 2025, 21:11 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 nov 2025, 21:11 UTC

Utili

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 nov 2025, 21:07 UTC

Utili

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 nov 2025, 21:05 UTC

Utili

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 nov 2025, 21:05 UTC

Utili

Palantir Technologies 3Q Net $475.6M >PLTR

Confronto tra pari

Modifica del prezzo

CEL-SCI Corp Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 0 che hanno fornito valutazioni azionarie a CEL-SCI Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

N/A / 0.2494Supporto e resistenza

Recent bearish events outweigh bullish events.

There is one bullish event.

There is one bearish event.

Sentiment

By Acuity

43 / 373 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Altri titoli del settore

JNJ

Johnson and Johnson

186.16

↓-1.49%

ABT

Abbott Laboratories

123.72

↑ +0.11%

TMO

Thermo Fisher Scientific Inc

565.18

↓-0.5%

ISRG

Intuitive Surgical Inc

544.08

↑ +1.81%

DHR

Danaher Corp

214.08

↓-0.71%

CEL-SCI Corp

Panoramica

Variazione del prezzo dell'azione

Metriche Chiave

Statistiche di mercato

Notizie sul Sentiment di mercato

Punteggio Tecnico

CEL-SCI Corp Grafico

Notizie correlate

Confronto tra pari

CEL-SCI Corp Previsione

Consenso sulla valutazione

Punteggio Tecnico

Sentiment

Notizie finanziarie

Altri titoli del settore